Braskem (BAK) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- —
- Estimate
- $0.31
- Surprise
- —
- Score today
- 5.5/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Coverage in the report window
- Braskem Says Remains Committed To Consensual Solution For Capital Structure — benzinga, 2026-11-12
- Braskem Confirms It Didn’t Make 9 Nov Payment On R$1.2B 18th Debenture Issue, Says Non-Payment Covered By Court Stay Und — benzinga, 2026-11-12
Where TrendMatrix's rating stands now
TrendMatrix currently rates BAK Hold at 5.5/10; no pre/post engine snapshot brackets this report.
1 of the last 4 quarters beat the estimate.
What argues against it
- Market cap $255M below $400M minimum
- Momentum score 3.7/10 — below 4.5 minimum
- Reward/Risk 0.9:1 at current price — below 1.5:1 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $1.13
- Price target
- $1.29
- Stop
- $1.05
- Upside to target
- +14.2%
- Reward-to-risk
- 0.9:1
Risk check: RSI 28 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-11-13 — shown for context, not personalized investment advice.
BAK at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Chemicals
- Market cap
- $255.3M
- P/E (fwd)
- -1.0
- 52-week range
- $0.74–$5.39
- Off 52-week high
- 79.1%
- RSI (14)
- 28
- Volume vs avg
- 0.57×
- Score today
- 5.5/10